Structure-activity relationships related to ceftizoxime (FK 749).
D000818:Animals; D000900:Anti-Bacterial Agents; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology; D015296:Ceftizoxime; D002511:Cephalosporins / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D004355:Drug Stability; D004926:Escherichia coli / Q000187:drug effects; D007711:Klebsiella pneumoniae / Q000187:drug effects; D007769:Lactams; D051379:Mice; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D051381:Rats; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D007769:Lactams; C027318:nocardicin; D015296:Ceftizoxime; D002439:Cefotaxime